ARTICLE | Clinical News
Victoza liraglutide regulatory update
November 1, 2010 7:00 AM UTC
The U.K.'s NICE issued guidance recommending use of 1.2 mg Victoza liraglutide from Novo Nordisk to treat Type II diabetes in triple therapy regimens (in combination with metformin and a sulfonylurea ...